Hosted on MSN
Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment
David Luci, President and CEO, highlighted several significant developments, including the closing of a $2.5 million registered direct offering and the receipt of positive regulatory guidance from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results